14-70329194-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016468.7(COX16):āc.184T>Cā(p.Ser62Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000597 in 1,608,434 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_016468.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COX16 | NM_016468.7 | c.184T>C | p.Ser62Pro | missense_variant | 3/4 | ENST00000389912.7 | NP_057552.1 | |
SYNJ2BP-COX16 | NM_001202549.2 | c.340T>C | p.Ser114Pro | missense_variant | 4/5 | NP_001189478.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COX16 | ENST00000389912.7 | c.184T>C | p.Ser62Pro | missense_variant | 3/4 | 1 | NM_016468.7 | ENSP00000374562 | P1 | |
ENST00000655620.1 | n.713-13478A>G | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152076Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000484 AC: 12AN: 247890Hom.: 0 AF XY: 0.0000745 AC XY: 10AN XY: 134264
GnomAD4 exome AF: 0.0000632 AC: 92AN: 1456358Hom.: 0 Cov.: 30 AF XY: 0.0000773 AC XY: 56AN XY: 724660
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152076Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74276
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 01, 2022 | The c.184T>C (p.S62P) alteration is located in exon 3 (coding exon 3) of the COX16 gene. This alteration results from a T to C substitution at nucleotide position 184, causing the serine (S) at amino acid position 62 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2023 | COX16: PM2, BP4 - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at